The CB receptor agonist WIN 55,212-2 fails to elicit disruption of prepulse inhibition of the startle in Sprague-Dawley rats.
about
Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia PharmacotherapyEvaluation of sex differences in cannabinoid dependence.The role of cannabinoid 1 receptor expressing interneurons in behavior.Reversible disruption of pre-pulse inhibition in hypomorphic-inducible and reversible CB1-/- mice.Effect of social isolation on CB1 and D2 receptor and fatty acid amide hydrolase expression in rats.Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?Vulnerability Factors for the Psychiatric and Behavioral Effects of Cannabis.Drugs of abuse and increased risk of psychosis development.Association of Cannabis Use during Adolescence, Prefrontal CB1 Receptor Signaling, and SchizophreniaSensorimotor gating deficits in "two-hit" models of schizophrenia risk factors.Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia.Anxiolytic-like properties of the anandamide transport inhibitor AM404.Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies.Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on "tetrad", sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies.Corticosteroid dependent and independent effects of a cannabinoid agonist on core temperature, motor activity, and prepulse inhibition of the acoustic startle reflex in Wistar rats.Chronic cannabis promotes pro-hallucinogenic signaling of 5-HT2A receptors through Akt/mTOR pathway
P2860
Q28078534-7B9E0755-5694-422F-9B8F-87244AD8C6A5Q30415208-7A4126E4-440D-4CDF-9ABB-4E3EE142303EQ30417825-B4DCCE62-FFC6-48C2-916F-1D8BCBD15CE9Q30467877-9BC360D4-95BC-42F5-91D0-C8EF6BC8357CQ30489165-4ABDCE31-BDC0-4EF2-A56D-2AB9CA58FDC9Q31095554-C5CE7662-B37C-4A44-ADE4-FAB7B9021E68Q33664684-0B94F455-2761-4639-A3B4-24B184FB2866Q34290364-6E414353-1A2E-41F8-8165-CD0CB5BAA4A2Q35990574-B1365BD1-2F13-4FA0-BA29-BC50E3F309C6Q46096598-E9283EC0-84B4-45AA-AFD7-5881CC05B746Q46370479-27129C2D-459A-4F96-9C32-18296A4DE1E0Q46689323-3A06DA1F-5F96-4DB8-B05F-FE757BC82479Q48301733-77F00410-04B0-4C8A-A650-81919ED5E95DQ48569237-55E3A1C2-12FE-49DE-9201-9E62D756D012Q51852884-A9DB34FD-F791-4DA7-A0D4-1EE01331D697Q57647123-969BCF86-8FAA-4DA3-B2AE-E80AEAF03240
P2860
The CB receptor agonist WIN 55,212-2 fails to elicit disruption of prepulse inhibition of the startle in Sprague-Dawley rats.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
The CB receptor agonist WIN 55 ...... tartle in Sprague-Dawley rats.
@en
The CB receptor agonist WIN 55 ...... tartle in Sprague-Dawley rats.
@nl
type
label
The CB receptor agonist WIN 55 ...... tartle in Sprague-Dawley rats.
@en
The CB receptor agonist WIN 55 ...... tartle in Sprague-Dawley rats.
@nl
prefLabel
The CB receptor agonist WIN 55 ...... tartle in Sprague-Dawley rats.
@en
The CB receptor agonist WIN 55 ...... tartle in Sprague-Dawley rats.
@nl
P2093
P2860
P1433
P1476
The CB receptor agonist WIN 55 ...... tartle in Sprague-Dawley rats.
@en
P2093
Gian Luigi Gessa
Gian Nicola Aru
Gianluca Boi
Grant Christopher Luckey
Marco Orrù
P2860
P2888
P304
P356
10.1007/S00213-004-1941-4
P577
2004-07-28T00:00:00Z